Ascendis Pharma A/S (ASND) News Today $155.50 +4.51 (+2.99%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Is Ascendis Pharma A/S (ASND) the Best Growth Stock to Buy According to Billionaires?April 14 at 3:18 PM | insidermonkey.comAscendis Pharma (ASND) Receives a Buy from Evercore ISIApril 14 at 11:54 AM | markets.businessinsider.comEvolutionary Tree Capital Management LLC Has $4.15 Million Holdings in Ascendis Pharma A/S (NASDAQ:ASND)Evolutionary Tree Capital Management LLC reduced its stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 8.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 30,115 shares of the biotechnology company's stock after selliApril 14 at 7:35 AM | marketbeat.comSterling Capital Management LLC Purchases 9,065 Shares of Ascendis Pharma A/S (NASDAQ:ASND)Sterling Capital Management LLC grew its holdings in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 19.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 56,850 shares of the biotechnoloApril 14 at 6:25 AM | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Shares Purchased by FIL LtdFIL Ltd lifted its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 13.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 729,275 shares of the biotechnology company's stock after purchasing aApril 12 at 6:08 AM | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Shares Down 7.4% - Should You Sell?Ascendis Pharma A/S (NASDAQ:ASND) Stock Price Down 7.4% - What's Next?April 11 at 12:34 PM | marketbeat.comFmr LLC Sells 179,199 Shares of Ascendis Pharma A/S (NASDAQ:ASND)Fmr LLC trimmed its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 3.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,728,647 shares of the biotechnology company's stock after selling 17April 11 at 5:44 AM | marketbeat.comADAR1 Capital Management LLC Has $9.83 Million Position in Ascendis Pharma A/S (NASDAQ:ASND)ADAR1 Capital Management LLC lowered its position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 55.8% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 71,402 shares of the biotechnology company's stock after selling 90,April 9, 2025 | marketbeat.comFinepoint Capital LP Reduces Stock Holdings in Ascendis Pharma A/S (NASDAQ:ASND)Finepoint Capital LP trimmed its stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 2.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 184,872 shares of the biotechnology company's stock after selling 5,200 sharApril 8, 2025 | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Shares Bought by Trexquant Investment LPTrexquant Investment LP lifted its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 235.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,067 shares of the biotechnology compaApril 8, 2025 | marketbeat.comAlliancebernstein L.P. Sells 9,760 Shares of Ascendis Pharma A/S (NASDAQ:ASND)Alliancebernstein L.P. trimmed its holdings in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 2.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 445,028 shares of the biotechnology company's stock after selling 9,760April 7, 2025 | marketbeat.comWellington Management Group LLP Lowers Position in Ascendis Pharma A/S (NASDAQ:ASND)Wellington Management Group LLP trimmed its position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 44.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 704,175 shares of thApril 5, 2025 | marketbeat.comSchroder Investment Management Group Purchases 11,739 Shares of Ascendis Pharma A/S (NASDAQ:ASND)Schroder Investment Management Group increased its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 14.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 92,728 shares of the biotechnology company's stock after buying an additionalApril 5, 2025 | marketbeat.comNomura Asset Management Co. Ltd. Purchases 2,506 Shares of Ascendis Pharma A/S (NASDAQ:ASND)Nomura Asset Management Co. Ltd. boosted its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 13.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 20,506 shares of the biotechApril 4, 2025 | marketbeat.comNew Age Alpha Advisors LLC Invests $507,000 in Ascendis Pharma A/S (NASDAQ:ASND)New Age Alpha Advisors LLC bought a new position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 3,680 shares of the biotechnology company's stock, valued at approximately $507,000.April 3, 2025 | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Shares Sold by Groupama Asset ManagmentGroupama Asset Managment trimmed its holdings in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 1.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 400,000 shares of the biotechnology company's stock after selling 4,000 shares duriApril 2, 2025 | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Shares Sold by Pictet Asset Management Holding SAPictet Asset Management Holding SA reduced its holdings in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 6.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 144,199 shares of the biotechnology company's stock afterApril 2, 2025 | marketbeat.comAscendis Pharma submits TransCon CNP NDA to FDAApril 1, 2025 | markets.businessinsider.comAscendis Submits U.S. NDA for TransCon CNP (Navepegritide) for the Treatment of Children with AchondroplasiaMarch 31, 2025 | globenewswire.comHighTower Advisors LLC Takes $484,000 Position in Ascendis Pharma A/S (NASDAQ:ASND)HighTower Advisors LLC acquired a new position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 3,514 shares of the biotechnology company's stock, valued at approximately $484,00March 31, 2025 | marketbeat.comLoomis Sayles & Co. L P Sells 5,724 Shares of Ascendis Pharma A/S (NASDAQ:ASND)Loomis Sayles & Co. L P cut its holdings in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 3.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 178,899 shares of the biotechnology company's stock after selling 5,724 shares duriMarch 30, 2025 | marketbeat.comNEOS Investment Management LLC Has $2.62 Million Stake in Ascendis Pharma A/S (NASDAQ:ASND)NEOS Investment Management LLC raised its position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 43.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,040 shares of the biotechnology company'sMarch 30, 2025 | marketbeat.comCorient Private Wealth LLC Takes Position in Ascendis Pharma A/S (NASDAQ:ASND)Corient Private Wealth LLC bought a new position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 3,271 shares of the biotechnology company's stoMarch 30, 2025 | marketbeat.comAscendis Pharma Closes Warrant Exercise Window, Boosts Share CapitalMarch 28, 2025 | tipranks.comBIT Capital GmbH Has $10.19 Million Position in Ascendis Pharma A/S (NASDAQ:ASND)BIT Capital GmbH grew its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 8.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 73,990 shares of the biotechnology company's stock after acquMarch 28, 2025 | marketbeat.comArtisan Partners Limited Partnership Increases Stake in Ascendis Pharma A/S (NASDAQ:ASND)Artisan Partners Limited Partnership raised its holdings in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 0.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,450,420 shares of the bioMarch 28, 2025 | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Shares Acquired by American Century Companies Inc.American Century Companies Inc. increased its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 17.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 407,294 shares of the biotechnologyMarch 27, 2025 | marketbeat.comHere's How Much $100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth TodayMarch 25, 2025 | benzinga.comAscendis Pharma A/S (NASDAQ:ASND) Given Average Rating of "Moderate Buy" by BrokeragesShares of Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the fourteen brokerages that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and thirteen have issMarch 25, 2025 | marketbeat.comSei Investments Co. Sells 10,165 Shares of Ascendis Pharma A/S (NASDAQ:ASND)Sei Investments Co. lowered its holdings in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 3.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 263,582 shares of the biotechnology company'sMarch 25, 2025 | marketbeat.comThrivent Financial for Lutherans Decreases Position in Ascendis Pharma A/S (NASDAQ:ASND)Thrivent Financial for Lutherans reduced its stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 54.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 35,941 shares of the biotechnology company's stock afterMarch 25, 2025 | marketbeat.comProficio Capital Partners LLC Acquires New Position in Ascendis Pharma A/S (NASDAQ:ASND)Proficio Capital Partners LLC bought a new position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 12,528 shares of the biotechnology companMarch 20, 2025 | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Price Target Raised to $200.00JPMorgan Chase & Co. upped their price target on shares of Ascendis Pharma A/S from $168.00 to $200.00 and gave the company an "overweight" rating in a report on Tuesday.March 19, 2025 | marketbeat.comAscendis Pharma price target raised to $200 from $168 at JPMorganMarch 19, 2025 | markets.businessinsider.comTD Cowen Sticks to Their Buy Rating for Ascendis Pharma (ASND)March 18, 2025 | markets.businessinsider.comAscendis Pharma A/S (NASDAQ:ASND) Reaches New 52-Week High - Time to Buy?Ascendis Pharma A/S (NASDAQ:ASND) Reaches New 12-Month High - Still a Buy?March 18, 2025 | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Shares Sold by Bank of New York Mellon CorpBank of New York Mellon Corp lessened its holdings in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 6.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 98,392 shares of the biotechnology company's stock afterMarch 13, 2025 | marketbeat.comVictory Capital Management Inc. Sells 2,505 Shares of Ascendis Pharma A/S (NASDAQ:ASND)Victory Capital Management Inc. decreased its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 1.9% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 131,353 shares of the biotechnology company's stock after selling 2,505 shares during the peMarch 12, 2025 | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Shares Sold by Candriam S.C.A.Candriam S.C.A. decreased its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 0.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 280,154 shares of the biotechnology company's stockMarch 7, 2025 | marketbeat.com12,528 Shares in Ascendis Pharma A/S (NASDAQ:ASND) Purchased by Proficio Capital Partners LLCProficio Capital Partners LLC bought a new stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 12,528 shares of the biotechnology company's stock, valued at approximately $1March 7, 2025 | marketbeat.comTD Cowen Sticks to Its Buy Rating for Ascendis Pharma (ASND)March 5, 2025 | markets.businessinsider.comHenry James International Management Inc. Trims Holdings in Ascendis Pharma A/S (NASDAQ:ASND)Henry James International Management Inc. decreased its holdings in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 16.4% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,851 shares of the biotechnology comMarch 2, 2025 | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Sets New 1-Year High - Here's WhyAscendis Pharma A/S (NASDAQ:ASND) Sets New 1-Year High - What's Next?March 1, 2025 | marketbeat.comCantor Fitzgerald Comments on ASND FY2025 EarningsAscendis Pharma A/S (NASDAQ:ASND - Free Report) - Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Ascendis Pharma A/S in a research note issued on Tuesday, February 25th. Cantor Fitzgerald analyst L. Watsek anticipates that the biotechnolFebruary 28, 2025 | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Given Average Rating of "Moderate Buy" by AnalystsAscendis Pharma A/S (NASDAQ:ASND - Get Free Report) has received an average recommendation of "Moderate Buy" from the fourteen brokerages that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and thirteen have assigned a buy recommFebruary 28, 2025 | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Shares Sold by Handelsbanken Fonder ABHandelsbanken Fonder AB lessened its stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 22.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 13,667 shares of the biotechnology company's stock after selling 4,000 shares during the period. HandelsbankenFebruary 26, 2025 | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Price Target Raised to $200.00 at Cantor FitzgeraldCantor Fitzgerald lifted their price target on shares of Ascendis Pharma A/S from $170.00 to $200.00 and gave the stock an "overweight" rating in a research note on Tuesday.February 25, 2025 | marketbeat.comAscendis Pharma to Participate in the TD Cowen 45th Annual Health Care ConferenceFebruary 24, 2025 | markets.businessinsider.comAscendis Pharma to Participate in the TD Cowen 45th Annual Health Care ConferenceFebruary 24, 2025 | globenewswire.comNew York State Common Retirement Fund Acquires 25,164 Shares of Ascendis Pharma A/S (NASDAQ:ASND)New York State Common Retirement Fund boosted its holdings in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 14.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 204,482 shares of the biotechnology company's stock aFebruary 21, 2025 | marketbeat.com Remove Ads Get Ascendis Pharma A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for ASND and its competitors with MarketBeat's FREE daily newsletter. Email Address ASND Media Mentions By Week ASND Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ASND News Sentiment▼1.571.00▲Average Medical News Sentiment ASND News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ASND Articles This Week▼116▲ASND Articles Average Week Remove Ads Get Ascendis Pharma A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for ASND and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARGX News Today ONC News Today BNTX News Today TEVA News Today ITCI News Today SMMT News Today GMAB News Today RDY News Today MRNA News Today VTRS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ASND) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersThe biggest story CNBC isn't talking about (yet)This Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredDeFi Coin on Verge of Breakout!Crypto’s down — but the fundamentals aren’t. Strategic investors are using this dip to scoop up undervalued...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ascendis Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Ascendis Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ASND Stock Free ASND Stock Alerts